Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmissible spongiform encephalopathies.

Steven J Collins1, Victoria A Lawson, Colin L Masters

  • 1Australian National Creutzfeldt-Jakob Disease Registry, Melbourne, Australia. stevenjc@unimelb.edu.au

Lancet (London, England)
|January 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19.

Journal of Alzheimer's disease : JAD·2020
Same author

Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology.

Alzheimer's research & therapy·2020
Same author

Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.

Journal of Alzheimer's disease : JAD·2020
Same author

Major risk factors for Alzheimer's disease: age and genetics.

The Lancet. Neurology·2020
Same author

Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease.

Neuroscience letters·2020
Same author

Differential blood miRNA expression in brain amyloid imaging-defined Alzheimer's disease and controls.

Alzheimer's research & therapy·2020
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Transmissible spongiform encephalopathies (TSEs), or prion diseases, share causes with Alzheimer's and Parkinson's but are distinct due to protein transmissibility. Vigilance against potential infectivity reservoirs is crucial for preventing future epidemics.

Area of Science:

  • Neuroscience
  • Pathology
  • Infectious Diseases

Background:

  • Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, are neurodegenerative disorders.
  • They share a common pathogenic mechanism with Alzheimer's and Parkinson's diseases: the toxic gain of function of aberrant proteins.
  • TSEs are unique due to the transmissibility of the abnormal protein structure.

Purpose of the Study:

  • To classify TSEs nosologically with other neurodegenerative disorders.
  • To explore the pathogenic mechanisms and transmissibility of prion diseases.
  • To reassess species barriers and infection control in light of new evidence.

Main Methods:

  • Comparative analysis of neurodegenerative disease mechanisms.
  • Review of epidemiological data on TSE outbreaks (e.g., bovine spongiform encephalopathy, kuru).

Related Experiment Videos

  • Evaluation of evidence for chronic subclinical infections in animals.

    • Main Results:

    • TSEs are nosologically grouped with Alzheimer's and Parkinson's, differing primarily in transmissibility.
    • The abnormal protein structure is key to TSE transmissibility.
    • Epidemics arise from sustained intraspecies recycling of the abnormal protein.
    • Chronic subclinical infections in animals inform pathogenesis and challenge existing notions of species barriers.

    Conclusions:

    • TSEs and other neurodegenerative diseases stem from protein misfolding and impaired clearance.
    • Transmissibility, inherent to the prion protein structure, distinguishes TSEs.
    • Sustained protein recycling can lead to major epidemics, necessitating ongoing surveillance.
    • Continued vigilance for infectivity reservoirs is essential to prevent TSE epidemics.